Chemical formula: C₂₁H₂₃N₃O₂ Molecular mass: 349.434 g/mol PubChem compound: 6918837
Panobinostat is indicated for:
Population group: only adults (18 - 65 years old)
Panobinostat, in combination with bortezomib and dexamethasone, is indicated for the treatment of adult patients with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Panobinostat is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
